- Supplier site
- Group of sites (click to zoom)
Scientist.com supplier network (site locations)
Research supplier
MDxHealth
MDxHealth is listed as a small business research supplier in the Scientist.com network, with 1 site in 1 country.
Sign in to Scientist.com to open this supplier in your organization's marketplace.
Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Services
What this research supplier says it provides, as listed in the Scientist.com network.
Type of company: Small business
Biomarkers
- Predictive Biomarkers Discovery Identify candidate biomarkers suggestive of a response to a treatment.
- Prognostic Biomarkers Discovery Identify candidate biomarkers representative of disease progression without treatment.
- Solid Tumor CDx Design and validate companion diagnostics for solid tumors that help select the most appropriate patients, identify patients at increased risk, or monitor treatment effectiveness.
Where it operates
Sites by country, with the cities in each.
-
United States 1 site
About this supplier
In the supplier's own words, as listed in the Scientist.com network.
MDxHealth is a molecular diagnostics company that develops and commercializes advanced epigenetic tests for cancer assessment and the personalized treatment of patients. Applying our patented DNA methylation platform and biomarkers, we help address a large and growing unmet medical need for better cancer diagnosis and treatment information. MDxHealth is a publicly-listed company trading on the NYSE Euronext (NYSE as in New York Stock Exchange) market of Brussels under the ticker symbol "MDXH". MDxHealth (formerly OncoMethylome Sciences) was established in 2003 and is headquartered...
Show the full description
MDxHealth is a molecular diagnostics company that develops and commercializes advanced epigenetic tests for cancer assessment and the personalized treatment of patients.
Applying our patented DNA methylation platform and biomarkers, we help address a large and growing unmet medical need for better cancer diagnosis and treatment information.
MDxHealth is a publicly-listed company trading on the NYSE Euronext (NYSE as in New York Stock Exchange) market of Brussels under the ticker symbol "MDXH".
MDxHealth (formerly OncoMethylome Sciences) was established in 2003 and is headquartered in Belgium. Its US headquarters is located in Irvine, CA.
MDxHealth develops molecular diagnostic products on its own or in partnership with pharmaceutical companies. Some of its products are already commercialized and the company has a broad pipeline of other products for major cancer indications.
- Website
- www.mdxhealth.com
Work with MDxHealth on Scientist.com
For prices, more details, or to contact MDxHealth, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.